Penn Medicine Abramson Cancer Center


 

ASH Updates on Large Cell & Aggressive Lymphomas: Antibody Loncastuximab Tesirine in R/R DLBCL, Glofitamab Step-Up Dosing in Hard-to-Treat R/R NHL, Subcutaneous Epcoritamab in R/R NHL, M-CHOP for DLBCL

159 views
March 2, 2021
0 Comments
Login to view comments. Click here to Login
New Therapies and Current Patient Management of Lymphomas